Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer Patients
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of AZD4547 in combination
with fulvestrant vs. fulvestrant alone in ER+ breast cancer patients with FGFR1 polysomy
(FISH4/5) or gene amplification (FISH 6)